Conformation of the Macrocyclic Drug Lorlatinib in Polar and Nonpolar Environments: A MD Simulation and NMR Study

Conformation of the Macrocyclic Drug Lorlatinib in Polar and Nonpolar Environments: A MD Simulation and NMR Study
复制标题

大环药物 Lorlatinib 在极性和非极性环境中的构象:MD 模拟和 NMR 研究

DOI:
--
复制
发表时间:
2019
期刊:
影响因子:
4.1
通讯作者:
M. Erdélyi
M. Erdélyi
中科院分区:
化学3区
文献类型:
--
作者:
Cheng Peng;Yoseph Atilaw;Jinan Wang;Zhijian Xu;Vasanthanathan Poongavanam;Jiye Shi;J. Kihlberg;Weiliang Zhu;M. Erdélyi

文献摘要

参考文献

被引文献

相似文献

副本交换分子动力学(REMD)模拟证明,很容易预测的大环药物劳拉替尼的构象,通过溶液NMR研究验证。在水溶液中,劳拉替尼采用与其目标结合结构相同的构象异构体。该构象异构体通过与溶剂的广泛氢键网络而稳定。在氯仿中,劳拉替尼占据两种构象,第二种构象极性较低,这可能有助于劳拉替尼穿过细胞膜的能力。
The replica exchange molecular dynamics (REMD) simulation is demonstrated to readily predict the conformations of the macrocyclic drug lorlatinib, as validated by solution NMR studies. In aqueous solution, lorlatinib adopts a conformer identical to its target bound structure. This conformer is stabilized by an extensive hydrogen bond network to the solvents. In chloroform, lorlatinib populates two conformers with the second one being less polar, which may contribute to lorlatinib’s ability to cross cell membranes.
DOI: 10.1039/c7md00464h
发表时间: 2018-01-01
期刊: MedChemComm
影响因子: --
作者:
Wang W;Groves MR;Dömling A
通讯作者: Dömling A
DOI: 10.1021/acs.jctc.8b00657
发表时间: 2019-01
影响因子: 5.5
作者:
Ardita Shkurti;I. D. Styliari;Vivek Balasubramanian;I. Bethune;Conrado Pedebos;S. Jha;C. Laughton
通讯作者: Ardita Shkurti;I. D. Styliari;Vivek Balasubramanian;I. Bethune;Conrado Pedebos;S. Jha;C. Laughton
DOI: 10.1021/ja0563455
发表时间: 2006-03-01
影响因子: 15
作者:
Rezai, T;Yu, B;Lokey, RS
通讯作者: Lokey, RS